180 related articles for article (PubMed ID: 16227779)
41. Transdermal clonidine application: long-term results in essential hypertension.
Groth H; Vetter H; Knüsel J; Foerster E; Siegenthaler W; Vetter W
Klin Wochenschr; 1984 Oct; 62(19):925-30. PubMed ID: 6503214
[TBL] [Abstract][Full Text] [Related]
42. A review of contact dermatitis associated with transdermal therapeutic systems.
Holdiness MR
Contact Dermatitis; 1989 Jan; 20(1):3-9. PubMed ID: 2492460
[TBL] [Abstract][Full Text] [Related]
43. Treatment of post-orchiectomy hot flashes with transdermal administration of clonidine.
Parra RO; Gregory JG
J Urol; 1990 Apr; 143(4):753-4. PubMed ID: 2313799
[TBL] [Abstract][Full Text] [Related]
44. Allergic contact dermatitis from a clonidine transdermal delivery system.
Corazza M; Mantovani L; Virgili A; Strumia R
Contact Dermatitis; 1995 Apr; 32(4):246. PubMed ID: 7600788
[No Abstract] [Full Text] [Related]
45. Treatment of hypertension by a new transdermal form of clonidine.
Gosse P; Wicker P; Roudaut R; Danays T; Dallocchio M
J Hypertens Suppl; 1985 Dec; 3(4):S65-7. PubMed ID: 3868714
[TBL] [Abstract][Full Text] [Related]
46. Clinical pharmacokinetics of clonidine.
Lowenthal DT; Matzek KM; MacGregor TR
Clin Pharmacokinet; 1988 May; 14(5):287-310. PubMed ID: 3293868
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of two-year therapy with transdermal clonidine for essential hypertension.
Horning JR; Zawada ET; Simmons JL; Williams L; McNulty R
Chest; 1988 May; 93(5):941-5. PubMed ID: 3282823
[TBL] [Abstract][Full Text] [Related]
48. Programmable transdermal clonidine delivery through voltage-gated carbon nanotube membranes.
Strasinger C; Paudel KS; Wu J; Hammell D; Pinninti RR; Hinds BJ; Stinchcomb A
J Pharm Sci; 2014 Jun; 103(6):1829-38. PubMed ID: 24788096
[TBL] [Abstract][Full Text] [Related]
49. Allergic contact dermatitis to transdermal clonidine.
Grattan CE; Kennedy CT
Contact Dermatitis; 1985 Apr; 12(4):225-6. PubMed ID: 3160534
[No Abstract] [Full Text] [Related]
50. Randomized, double-blind comparison of transdermal clonidine with oral propranolol.
Franklin SS; Tonkon MJ; Kirschenbaum MA; Dobak JD
J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S244-7. PubMed ID: 2455188
[TBL] [Abstract][Full Text] [Related]
51. [Effect of transdermal therapy with clonidine on suppression symptoms secondary to smoking cessation].
Cervantes Escárcega JL; Guadalajara Boo JF
Arch Inst Cardiol Mex; 1992; 62(5):435-40. PubMed ID: 1482222
[TBL] [Abstract][Full Text] [Related]
52. Transdermal clonidine skin reactions.
Prisant LM
J Clin Hypertens (Greenwich); 2002; 4(2):136-8. PubMed ID: 11927798
[TBL] [Abstract][Full Text] [Related]
53. Abrupt cessation of clonidine administration: a prospective study.
Whitsett TL; Chrysant SG; Dillard BL; Anton AH
Am J Cardiol; 1978 Jun; 41(7):1285-90. PubMed ID: 665535
[TBL] [Abstract][Full Text] [Related]
54. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes.
Goldberg RM; Loprinzi CL; O'Fallon JR; Veeder MH; Miser AW; Mailliard JA; Michalak JC; Dose AM; Rowland KM; Burnham NL
J Clin Oncol; 1994 Jan; 12(1):155-8. PubMed ID: 8270972
[TBL] [Abstract][Full Text] [Related]
55. Transdermal clonidine as an adjunct to enalapril: an evaluation of efficacy and patient compliance.
Weidler D; Wallin JD; Cook E; Dillard D; Lewin A
J Clin Pharmacol; 1992 May; 32(5):444-9. PubMed ID: 1587962
[TBL] [Abstract][Full Text] [Related]
56. Transdermal clonidine for hypertensive patients.
Popli S; Stroka G; Ing TS; Daugirdas JT; Norusis MJ; Hano JE; Gandhi VC
Clin Ther; 1983; 5(6):624-8. PubMed ID: 6627288
[TBL] [Abstract][Full Text] [Related]
57. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
McMahon FG; Jain AK; Vargas R; Fillingim J
Clin Ther; 1990; 12(2):88-100. PubMed ID: 2191779
[TBL] [Abstract][Full Text] [Related]
58. A community-based trial of transdermal antihypertensive therapy with clonidine (Catapres-TTS).
Kellaway GS; Lubbe WF
N Z Med J; 1986 Sep; 99(810):711-4. PubMed ID: 3547202
[TBL] [Abstract][Full Text] [Related]
59. Catapres-TTS: a two year posttrial followup.
Kellaway GS; Lubbe WF
N Z Med J; 1988 Jun; 101(847 Pt 1):380. PubMed ID: 2970607
[No Abstract] [Full Text] [Related]
60. Clonidine transdermal patches for use in outpatient opiate withdrawal.
Spencer L; Gregory M
J Subst Abuse Treat; 1989; 6(2):113-7. PubMed ID: 2664204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
